- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00942032
Clinical Experience With the Hindfoot Arthrodesis Nail for the Surgical Treatment of Ankle and Hindfoot Pathologies
April 6, 2011 updated by: AO Clinical Investigation and Publishing Documentation
Clinical Experience With the Hindfoot Arthrodesis Nail (HAN) for the Surgical Treatment of Ankle and Hindfoot Pathologies. A Retrospective Case Series.
The aim of this observational study is to collect and evaluate the current clinical experience gained from the Hindfoot Arthrodesis Nail (HAN) for ankle and hindfoot fusions.
Study Overview
Status
Completed
Conditions
Detailed Description
The HAN (Synthes) is a newly designed, titanium nail for trans-calcaneal, retrograde hindfoot fusion.
The lateral bend allows an entry site in the center of the lateral column of the calcaneus, thus minimizing the risk of iatrogenic injury of the plantar neurovascular bundle.
Study Type
Observational
Enrollment (Actual)
39
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France, 49933
- Centre hospitalier universitaire d'Angers
-
-
-
-
-
Berlin, Germany, 13353
- Charité Berlin, Campus Virchow Klinikum
-
Dresden, Germany, 01307
- Universitätsklinikum Carl Gustav Carus
-
-
-
-
-
Stockholm, Sweden, 11486
- Stockholms Fotkirurgklinik Sophiahemmet
-
-
-
-
California
-
Rancho Mirage, California, United States, 92270
- Eisenhower Medical Center
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Washington
-
Seattle, Washington, United States, 98104-2499
- Harborview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Eligible patients will be identified from the study sites' medical records, information systems, and OR logs.
The responsible local investigator or co-investigator at each study site will approach patients by letter or phone, and inquire about their interest in participating in this study.
Description
Inclusion Criteria:
- HAN fusion procedure ≥ 12 months before entering the study.
- Written or oral informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The aim of this observational study is to collect and evaluate the current clinical experience gained from the Hindfoot Arthrodesis Nail (HAN) for ankle and hindfoot fusions.
Time Frame: More than 1 year
|
More than 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Technical and surgical details Patient-centered endpoints (e.g., function as assessed by AAOS Foot and Ankle Outcomes Questionnaire (AAOS-FAOQ) score and the SF-36 Health Survey)
Time Frame: More than 1 year
|
More than 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Andrew K. Sands, MD, St. Vincent's Hospital, Foot and Ankle Surgery
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (ACTUAL)
April 1, 2011
Study Completion (ACTUAL)
April 1, 2011
Study Registration Dates
First Submitted
July 17, 2009
First Submitted That Met QC Criteria
July 17, 2009
First Posted (ESTIMATE)
July 20, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
April 7, 2011
Last Update Submitted That Met QC Criteria
April 6, 2011
Last Verified
April 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- HAN-09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hindfoot Arthrodesis
-
OrthoCarolina Research Institute, Inc.Pacira Pharmaceuticals, IncCompletedAnkle Arthrodesis | Hindfoot Arthrodesis | Tibitalocalceal ArthrodesisUnited States
-
Ferring PharmaceuticalsCompletedArthrodesis Surgery Involving the Hindfoot or AnkleUnited States, Canada
-
BioMimetic TherapeuticsUnknownAnkle and Hindfoot ArthrodesisUnited States, Canada
-
BioMimetic TherapeuticsUnknownAnkle and Hindfoot Arthrodesis
-
Orthofix Inc.CompletedTibiotalar Arthrodesis | Subtalar Arthrodesis | Calcaneocuboid Arthrodesis | Talonavicular Arthrodesis | Double Arthrodesis (i.e. Calcaneocuboid and Talonavicular) | Triple Arthrodesis (i.e. Subtalar, Calcaneocuboid, and Talonavicular)United States
-
Prisma Health-MidlandsMedical University of South CarolinaEnrolling by invitationAnkle Arthrodesis | MTP ArthrodesisUnited States
-
Integra LifeSciences ServicesTerminated
-
Virginia Spine InstituteCompleted
-
Universitaire Ziekenhuizen KU LeuvenRecruitingAnkle and Hindfoot AlterationsBelgium
-
Seoul National University HospitalCompletedArthrodesisKorea, Republic of